Russell Investments Group Ltd. cut its position in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 96.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 33,487 shares of the company's stock after selling 798,772 shares during the quarter. Russell Investments Group Ltd. owned about 0.07% of Xometry worth $1,429,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Xometry by 2.1% during the fourth quarter. Vanguard Group Inc. now owns 4,293,272 shares of the company's stock valued at $183,151,000 after buying an additional 86,997 shares during the last quarter. Geode Capital Management LLC boosted its position in Xometry by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 1,004,452 shares of the company's stock worth $42,861,000 after acquiring an additional 8,974 shares during the period. State Street Corp increased its holdings in shares of Xometry by 0.3% during the third quarter. State Street Corp now owns 887,139 shares of the company's stock valued at $16,297,000 after purchasing an additional 3,027 shares during the period. Baillie Gifford & Co. bought a new stake in shares of Xometry during the fourth quarter valued at about $30,297,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Xometry by 3.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 366,156 shares of the company's stock worth $15,620,000 after purchasing an additional 11,307 shares during the period. 97.31% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other news, COO Peter Goguen sold 3,000 shares of Xometry stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $35.57, for a total value of $106,710.00. Following the transaction, the chief operating officer now directly owns 161,993 shares of the company's stock, valued at $5,762,091.01. This trade represents a 1.82 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Emily Rollins sold 2,000 shares of the company's stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $20.66, for a total transaction of $41,320.00. Following the completion of the sale, the director now owns 16,146 shares of the company's stock, valued at approximately $333,576.36. This trade represents a 11.02 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 78,256 shares of company stock valued at $2,012,889. 16.79% of the stock is owned by corporate insiders.
Xometry Price Performance
Shares of NASDAQ XMTR traded down $0.13 during mid-day trading on Friday, reaching $24.73. The company had a trading volume of 71,937 shares, compared to its average volume of 604,303. Xometry, Inc. has a 1-year low of $11.08 and a 1-year high of $45.33. The stock has a market cap of $1.24 billion, a PE ratio of -23.64 and a beta of 0.72. The company has a current ratio of 4.59, a quick ratio of 4.55 and a debt-to-equity ratio of 0.90. The company has a 50-day moving average price of $25.16 and a two-hundred day moving average price of $29.47.
Analysts Set New Price Targets
A number of research firms have commented on XMTR. JPMorgan Chase & Co. dropped their price target on shares of Xometry from $45.00 to $30.00 and set an "overweight" rating on the stock in a research report on Tuesday. Royal Bank of Canada upped their target price on Xometry from $27.00 to $40.00 and gave the stock a "sector perform" rating in a research report on Friday, January 3rd. Citigroup lowered their price target on Xometry from $46.00 to $39.00 and set a "buy" rating on the stock in a research report on Thursday, February 27th. Cantor Fitzgerald upped their price objective on Xometry from $12.00 to $20.00 and gave the company an "underweight" rating in a report on Wednesday, February 26th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $42.00 target price on shares of Xometry in a research note on Monday, February 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $34.44.
Check Out Our Latest Stock Analysis on XMTR
About Xometry
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Recommended Stories

Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.